Paul Ramsey, founder of Ramsey Healthcare, and Natural Health International are bridging the gap between supplements and pharmaceuticals. Femmenessence™ offers women and mainstream medicine a naturally safe alternative that works. Five year published clinical trials and research reveal an 84% success rate in reducing menopausal symptoms.

San Francisco, CA (PRWEB) December 4, 2008 — Paul Ramsay is the founder and major shareholder in Ramsay Healthcare, one of the largest private hospital operators in the world with over 100 hospitals globally. Mr. Ramsay is now a significant shareholder in Natural Health International, the ground-breaking nutraceutical company that introduced Femmenessence™ to the US market. Femmenessence™ is the first herbal product with double blind placebo controlled clinical trials demonstrating statistically significant effects on the hormone levels of peri and post menopausal women. In these trials Femmenessence™ showed an 84% success rate in reducing menopausal symptoms such as hot flashes, night sweats and mood swings. Unlike other herbal options for post menopause Femmenessence™ increases levels of estradiol, progesterone, LH and thyroid hormone, while reducing FSH. The research also shows promise with respect to heart and bone health, with reductions in body weight, LDL, triglycerides and improvements in HDL, gastro intestinal absorption and bone density. The most interesting aspect of Femmenessence™ is its completely novel mode of action. Unlike HRT or bio identical hormones, it does not introduce hormones into the body, nor does it work like the black cohosh, soy or red clover. Rather Femmenessence™ supports the body’s own regulation of the complete hormonal profile through the Hypothalamus Pituitary Adrenal Axis.

"We are extremely excited to have Mr. Ramsay involved with NHI" said James Frame CEO of Natural Health International, "we understand that the future of healthcare must be an integrative approach but in order for that to become mainstream there must more quality control and clinical research relating to natural alternatives." Mr. Frame went on to discuss what would be required "…the most important thing is to get ride of the "us" and "them" attitude that currently exists and have clinical trials that combine pharmaceutical grade protocols with natural products of the quality and dose recommended by natural product industry experts. It is up to the natural products industry, of which we are a part, to set its own standards ensuring customers have guarantees of quality, efficacy and safety. Every herb we have ever researched works, the issue is making sure you provide the customer with a quality, stable, bio-available dose."

Natural Health International’s catch phrase – "bridging the gap between supplements and pharmaceuticals" defines their strong scientific and clinical focus. The company is also responsible for the first plant based melatonin product on the market – Herbatonin®.

Natural Health International is unique in the natural products industry combining species, phenotype selection and organic and biodynamic type farm practices with proprietary manufacturing processes for each individual herb. Also distinguished by its scientific and clinical research, the company’s vertical integration ensures control of the whole manufacturing process from seed to shelf. With a head office in San Francisco, NHI oversees operations in Vanuatu, Australia, New Zealand, France, Peru and Asia. Natural Health International is launching Femmenessence™ in the UK and Canada and will be expanding its retail presence to include Europe, Australia, Japan, Korea and other parts of Asia in 2009.

For more information contact:
Natural Health International
James Frame
(415) 243- 9992


Read the full story at